DK2918286T3 - En farmaceutisk formulering - Google Patents

En farmaceutisk formulering Download PDF

Info

Publication number: DK2918286T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 2004-10-05

Application number

DK15161696.8T

Other languages

English (en)

Inventor

Petter Berglund

Charlotte Hammelev

Lone Eskildsen

Johanne Madsen

Helle Aalund Olsen

Lone Løgstrup Kimer

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-05

Filing date

2005-10-05

Publication date

2020-03-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35428106&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2918286(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-10-05 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2020-03-30 Application granted granted Critical

2020-03-30 Publication of DK2918286T3 publication Critical patent/DK2918286T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Obesity (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK15161696.8T 2004-10-05 2005-10-05 En farmaceutisk formulering DK2918286T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200401519		2004-10-05
EP20050792052 EP1802329B1 (en)	2004-10-05	2005-10-05	A pharmaceutical formulation comprising crystalline insulin and dissolved insulin

Publications (1)

Publication Number	Publication Date
DK2918286T3 true DK2918286T3 (da)	2020-03-30

Family

ID=35428106

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK15161696.8T DK2918286T3 (da)	2004-10-05	2005-10-05	En farmaceutisk formulering

Country Status (19)

Country	Link
US (1)	US7884181B2 (da)
EP (4)	EP2926828B1 (da)
JP (1)	JP5080259B2 (da)
KR (1)	KR101238184B1 (da)
CN (2)	CN102772788B (da)
AU (1)	AU2005291233B2 (da)
BR (1)	BRPI0516464B8 (da)
CA (1)	CA2581798A1 (da)
CY (1)	CY1124650T1 (da)
DK (1)	DK2918286T3 (da)
ES (3)	ES2779957T3 (da)
HU (1)	HUE048806T2 (da)
LT (1)	LT2918286T (da)
MX (1)	MX2007003897A (da)
PL (2)	PL2918286T3 (da)
PT (1)	PT2918286T (da)
RU (1)	RU2389503C2 (da)
SI (1)	SI2918286T1 (da)
WO (1)	WO2006037789A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008065138A1 (en) *	2006-11-29	2008-06-05	Novo Nordisk A/S	Novel insulin crystal and method for preparing the crystal
CN102219851B (zh) *	2011-05-09	2012-05-30	甘李药业有限公司	甘精胰岛素结晶的制备方法
AU2013368990B2 (en) *	2012-12-26	2017-05-18	Wockhardt Limited	Pharmaceutical composition
JP6641280B2 (ja)	2014-01-09	2020-02-05	サノフイＳａｎｏｆｉ	インスリンアナログおよび／またはインスリン誘導体の安定化された医薬製剤
RU2014120626A (ru) *	2014-05-22	2015-11-27	Владимир Андреевич Сабецкий	Инсулинсодержащий препарат пролонгированного действия
CN105535942B (zh) *	2016-01-28	2017-07-28	通化东宝药业股份有限公司	一种赖脯胰岛素硫酸鱼精蛋白制剂的制备方法及其制备的赖脯胰岛素硫酸鱼精蛋白制剂
WO2017163159A1 (en) *	2016-03-21	2017-09-28	Wockhardt Limited	Biphasic pharmaceutical composition of insulin human
CN113384529B (zh) *	2021-07-08	2021-11-26	北京惠之衡生物科技有限公司	一种门冬胰岛素注射液及其制备方法
CN113248591B (zh) *	2021-07-08	2021-09-28	北京惠之衡生物科技有限公司	一种门冬胰岛素结晶工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB889769A (en) *	1957-07-18	1962-02-21	Nordisk Insulinlab	Slowly acting insulin preparation in crystalline form
DK72793D0 (da)	1993-06-21	1993-06-21	Novo Nordisk As	Nyt produkt
US5461031A (en) *	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations
US5474978A (en)	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
US5866538A (en)	1996-06-20	1999-02-02	Novo Nordisk A/S	Insulin preparations containing NaCl
ATE369146T1 (de) *	1996-06-20	2007-08-15	Novo Nordisk As	Insulinpreparation mit mannitol
CN1120019C (zh)	1996-06-20	2003-09-03	诺沃挪第克公司	含NaCl的胰岛素制品
US5948751A (en)	1996-06-20	1999-09-07	Novo Nordisk A/S	X14-mannitol
HUP0700126A2 (en) *	2001-12-20	2007-06-28	Lilly Co Eli	Insulin molecule having protracted time action
JP2006519791A (ja) *	2003-03-13	2006-08-31	ノボ　ノルディスク　アクティーゼルスカブ	新規なｎｐｈインスリン製剤

2005
- 2005-10-05 KR KR1020077007794A patent/KR101238184B1/ko not_active Expired - Fee Related
- 2005-10-05 ES ES15161696T patent/ES2779957T3/es active Active
- 2005-10-05 WO PCT/EP2005/055017 patent/WO2006037789A1/en active Application Filing
- 2005-10-05 EP EP15160523.5A patent/EP2926828B1/en active Active
- 2005-10-05 US US11/664,407 patent/US7884181B2/en active Active - Reinstated
- 2005-10-05 DK DK15161696.8T patent/DK2918286T3/da active
- 2005-10-05 SI SI200532272T patent/SI2918286T1/sl unknown
- 2005-10-05 ES ES05792052.2T patent/ES2544329T3/es active Active
- 2005-10-05 EP EP15161696.8A patent/EP2918286B1/en active Active
- 2005-10-05 EP EP20050792052 patent/EP1802329B1/en active Active
- 2005-10-05 CA CA002581798A patent/CA2581798A1/en not_active Withdrawn
- 2005-10-05 PL PL15161696T patent/PL2918286T3/pl unknown
- 2005-10-05 LT LTEP15161696.8T patent/LT2918286T/lt unknown
- 2005-10-05 PL PL05792052T patent/PL1802329T3/pl unknown
- 2005-10-05 MX MX2007003897A patent/MX2007003897A/es active IP Right Grant
- 2005-10-05 RU RU2007111879/15A patent/RU2389503C2/ru active
- 2005-10-05 AU AU2005291233A patent/AU2005291233B2/en not_active Ceased
- 2005-10-05 JP JP2007535163A patent/JP5080259B2/ja active Active
- 2005-10-05 CN CN201210248925.9A patent/CN102772788B/zh active Active
- 2005-10-05 EP EP20158951.2A patent/EP3689366A1/en not_active Withdrawn
- 2005-10-05 BR BRPI0516464A patent/BRPI0516464B8/pt not_active IP Right Cessation
- 2005-10-05 PT PT151616968T patent/PT2918286T/pt unknown
- 2005-10-05 HU HUE15161696A patent/HUE048806T2/hu unknown
- 2005-10-05 ES ES15160523T patent/ES2774354T3/es active Active
- 2005-10-05 CN CN2005800339452A patent/CN101035557B/zh active Active
2020
- 2020-03-23 CY CY20201100270T patent/CY1124650T1/el unknown

Also Published As

Publication number	Publication date
AU2005291233B2 (en)	2011-02-03
EP2926828A1 (en)	2015-10-07
EP3689366A1 (en)	2020-08-05
MX2007003897A (es)	2007-05-21
CN102772788A (zh)	2012-11-14
CY1124650T1 (el)	2022-03-24
RU2389503C2 (ru)	2010-05-20
CN101035557A (zh)	2007-09-12
JP5080259B2 (ja)	2012-11-21
BRPI0516464B8 (pt)	2021-05-25
US20080171694A1 (en)	2008-07-17
PT2918286T (pt)	2020-03-27
SI2918286T1 (sl)	2020-06-30
CA2581798A1 (en)	2006-04-13
ES2544329T3 (es)	2015-08-28
PL1802329T3 (pl)	2015-10-30
KR20070100874A (ko)	2007-10-12
HUE048806T2 (hu)	2020-08-28
EP2926828B1 (en)	2019-12-11
AU2005291233A1 (en)	2006-04-13
US7884181B2 (en)	2011-02-08
EP2918286A1 (en)	2015-09-16
KR101238184B1 (ko)	2013-03-04
EP1802329B1 (en)	2015-05-06
CN102772788B (zh)	2017-06-06
EP1802329A1 (en)	2007-07-04
BRPI0516464A (pt)	2008-09-09
EP2918286B1 (en)	2020-03-18
BRPI0516464B1 (pt)	2016-11-08
LT2918286T (lt)	2020-04-10
WO2006037789A1 (en)	2006-04-13
JP2008515853A (ja)	2008-05-15
PL2918286T3 (pl)	2020-06-29
ES2779957T3 (es)	2020-08-20
CN101035557B (zh)	2012-09-05
RU2007111879A (ru)	2008-11-20
ES2774354T3 (es)	2020-07-20

Publication	Publication Date	Title
NL301229I2 (nl)	2023-11-23	Deoxycholaat
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
DE602005026188D1 (de)	2011-03-17	Medikamentenspender
NO20075628L (no)	2007-11-05	Farmasøytiske formuleringer
DK2073795T3 (da)	2014-02-03	Misbrugssikret lægemiddelformulation
DE602005016579D1 (de)	2009-10-22	Abgabevorrichtung
ITBO20050123A1 (it)	2005-06-06	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
DK1957073T3 (da)	2014-05-12	Lægemiddel
DK1907037T4 (da)	2022-11-07	Lægemiddeldispenser
EP1992348A4 (en)	2009-09-23	PHARMACEUTICAL COMBINATION
DK3437682T3 (da)	2022-05-16	Lægemiddeladministrationsanordning
ATE412651T1 (de)	2008-11-15	Pyrrolopyridinderivate
DK1757293T3 (da)	2012-10-22	Bh4-responsiv hyperphenylalaninæmi-medikamenter
DK2918286T3 (da)	2020-03-30	En farmaceutisk formulering
EP1819352A4 (en)	2010-03-03	PHARMACEUTICAL COMPOSITIONS FROM CARAPA GUIANENSIS
DE502005001451D1 (de)	2007-10-25	Fugenabdeckprofil
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina
NO20034952D0 (no)	2003-11-06	Farmasöytiske forbindelser
IS7581A (is)	2004-12-03	Lyfjasamsetning
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
NO20045424D0 (no)	2004-12-14	Ingrediensbeholder
FR2879415B1 (fr)	2007-04-20	Epingle a chignon
DE602005005033D1 (de)	2008-04-10	Sprühgetrocknete pharmazeutische zusammensetzungen
GB0522473D0 (en)	2005-12-14	A pharmaceutical formulation
EP1747205A4 (en)	2008-02-13	PHARMACEUTICAL COMPOSITIONS